'The Holy Grail'
Although much progress has been made in understanding the molecular details of how Gα subunits interact with and regulate the activity of their downstream targets, it is less clear how activated GPCRs initiate this process by catalyzing nucleotide exchange on Gαβγ. This question is of great importance not only because it represents an essential, pharmacologically relevant interaction but also because an atomic understanding of this process is key to unlocking the secrets of functional selectivity, the ability of consistent with the idea that switch II is a critical component of the effector binding site because it would provide a molecular explanation for how GTP hydrolysis is coupled to loss of effector binding and regulation. The importance of the switch II helix was confirmed by the structure of Gα s in complex with the catalytic domains of adenylyl cyclase in 1997 (ref. 4) (Fig. 1, bottom) . Over the following ten years, structures of four other Gα-effector complexes were determined, and in each case, the effectors have likewise formed extensive contacts with switch II 3 .
Pioneering work by Rall and Sutherland in the late 1950s revealed that hormones such as epinephrine and glucagon interact with receptors in liver cell membranes to elicit the production of cyclic-3′,5′-monophosphate (cAMP) by adenylyl cyclase 1 . Over the next two decades, it was established that these integral membrane receptors, once activated, convey their signals in a GTP-dependent manner via a complex of three proteins known as the heterotrimeric G proteins, or Gαβγ 2 . Consequently, the targets of epinephrine and glucagon are now known as G protein-coupled receptors (GCPRs), a large family of proteins recognized for their ability to induce profound physiological change in response to diverse extracellular signals. The Gα subunit shares homology with Ras and binds guanine nucleotides in a signal-dependent manner, whereas the Gβγ heterodimer has high affinity for the GDP-bound state of Gα and is released from Gα·GTP after receptor activation (Fig. 1) . During the 1990s, structural biologists began to tease apart the molecular basis for heterotrimeric G protein function, and highresolution crystal structures representing the Gα subunit in its active (GTP-bound), deactivated (GDP-bound) and inactive (Gαβγ complex) states were determined 3 . In the activated state of Gα, the γ-phosphate of GTP stabilizes the structure of the second helix of the Ras-like domain. This helix, known as switch II, is disordered in the GDP-bound state and is sequestered when in complex with Gβγ. These observations were Figure 1 The heterotrimeric G protein cycle. The inactive Gαβγ heterotrimer (top) is composed of two principal elements, Gα·GDP (cyan, with GDP shown in grey with magenta dot surface) and the Gβγ heterodimer (blue and green). Gβγ sequesters the switch II element (red) such that it is unable to interact with effectors. Activated GPCRs catalyze the release of GDP from Gα, allowing GTP to bind and liberate the activated Gα·GTP subunit (right). In this state, switch II forms a helix stabilized by the γ-phosphate of GTP. The activated Gα subunit can then interact with effectors, such as the catalytic domains of adenylyl cyclase (bottom, gold and dark green). Switch II forms a major component of the interface, as it does in other characterized effector complexes. The Gα subunit has a slow GTPase activity that converts GTP to GDP, weakening its interactions with effectors and allowing it to dissociate as a deactivated Gα·GDP subunit (left). In this state, switch II is disordered (red dotted line), and the protein has high affinity for Gβγ subunits, completing the cycle. The structures shown correspond to PDB entries 1GG2 (ref. 27) (top, cyan subunit corresponds to Gα i ), 1AZT 28 
S I G N A L I N T E G R AT I O N
c o m m e n ta ry it difficult to determine how heterotrimeric G proteins interact with receptors. However, a glimpse of the answer came with the crystal structure of bovine opsin 14 , a retinal-depleted form of rhodopsin that, like the β 2 AR, has constitutive activity. Unexpectedly, opsin assumed a conformation consistent with properties of Meta II, the fully activated state of rhodopsin, predicted by biophysical measurements 15, 16 , including a rigid body rotation of TM6 away from the core of the receptor (thus breaking the ionic lock) to form a solvent-accessible cavity and a docking site for the C terminus of Gα on the inside of the cytoplasmic ends of TM5 and TM6 (Fig. 2a) . The follow-up structure of opsin in complex with a peptide derived from the C terminus of transducin (Gα t ) confirmed these predictions 17 . The Gα t peptide makes direct contact with residues known to be important for heterotrimeric G protein activation, such as the side chain of the highly conserved arginine that constitutes part of the ionic lock, and forms specific interactions that help to explain the molecular basis of specificity between GPCRs and heterotrimeric G proteins.
insight into G protein coupling. Structures soon followed for the β 1 -adrenergic receptor 11 , a squid photoreceptor that couples with Gα q (ref. 12) and the adenosine A 2A receptor 13 , which were likewise determined in inactive states. Furthermore, it was not clear to what conformational state any of these structures corresponded, because the so-called 'ionic lock' , a salt bridge linking residues between TM3 and TM6 believed to be characteristic of the inactive state of the receptor, was not formed as it is in the structure of rhodopsin. Although these structures each represented major advances in our understanding of GPCRs, they left the activated state of the receptor and the molecular mechanism of G protein coupling in the dark.
Light at the end of the tunnel
With five unique, but inactive, receptor structures, the preponderance of evidence appeared to suggest that only an inhibited GPCR could assume a sufficiently rigid conformation amenable for crystallization, or at least that receptors would have to be engineered in a way (for example, by lysozyme insertion) that would render different agonists to coerce distinct downstream effects from a single kind of GPCR 4 . Functional selectivity at the level of the GPCR manifests itself in the differential ability of certain ligands to 'bias' the conformation of the receptor such that it interacts preferentially with either heterotrimeric G proteins or one of its other downstream targets 6 . These targets include the GPCR kinases (GRKs), which phosphorylate activated GPCRs, and the arrestins, which bind these phosphorylated GPCRs and target them for clathrin-mediated endocytosis. Clearly, the conformational state of a receptor that optimally recognizes a heterotrimeric G protein is not necessarily the same as those that optimally recognize GRKs or arrestins. Thus, receptors can initiate signals to both traditional and G proteinindependent pathways and can control the relative activity of these cascades according to the chemical nature of the bound ligand.
The first crystal structure of a GPCR was that of bovine rhodopsin, reported in 2000 (ref. 7) . Whereas electron microscopy studies had successfully revealed the topology of the seven transmembrane spans of the receptor, the crystal structure provided the framework for understanding a large body of biochemical analyses and fostered many experiments aimed at understanding how specific side chains and water molecules within the transmembrane region provide an allosteric conduit between the agonist and heterotrimeric G protein binding sites. The rhodopsin structure, however, left the molecular mechanism of G protein coupling ambiguous, for the receptor comes with its own covalently bound inverse agonist, 11-cis-retinal, a ligand that completely suppresses the basal activity of the receptor and locks the receptor in a rigid state. In particular, intracellular loop 3 (IL3), which connects the fifth and sixth transmembrane spans (TM5 and TM6, respectively) and is strongly implicated in heterotrimeric G protein binding, was poorly ordered. Indeed, subsequent crystal structures of rhodopsin yielded different configurations of this loop 8 .
Seven years later, two atomic structures of the β 2 -adrenergic receptor (β 2 AR) were determined 9, 10 . Unlike rhodopsin, the β 2 AR has significant basal activity, implying that the receptor can sample multiple conformational states in the absence of ligands, which hindered efforts to crystallize the protein. This problem was circumvented by replacing much of IL3 with the rigid structural domain of T4 lysozyme or by using a Fab fragment that recognizes the same loop. Perhaps most importantly, both structures were determined in the presence of carazolol, a partial inverse agonist that, like 11-cis retinal for rhodopsin, helps lock the receptor in an inactive state. As a consequence, these structures could not provide much additional 31 and the C-terminus of Gγ according to PDB entry 1OMW 32 . The C-terminal span of Gα i analogous to the Gα t peptide bound to opsin is colored yellow. Comparing the orientation of this helix in each model reveals an apparent docking incompatibility, because the intact heterotrimer would have to be rotated, roughly counterclockwise, up into the plane of the lipid bilayer in order to superimpose these elements. (c) Collision of Gαβγ with the lipid bilayer when superimposed with the Gα t peptide bound to opsin. The collision suggests that either the model of opsin does not represent a GPCR in a fully activated state, or the G protein heterotrimer must undergo a significant conformational change, or both. A large conformational change is expected in Gαβγ because its interaction with receptors must induce nucleotide release.
co m m e n ta ry and arrestins are also lipid-dependent downstream targets of activated GPCRs, and thus, an analogous mechanism may be dictating their specific interactions with receptors.
In the end, what will be required to truly attain the grail is the crystal structure of a GPCR in complex with a heterotrimeric G protein, as this would most clearly delineate the features of a receptor in its high-affinity, G protein-bound state. Interestingly, there are at least three grails. Structures of GPCRs in complex with GRKs and with arrestins will also be required to define the activated receptor in two other distinct, physiologically relevant signaling states.
ejected from the active site of Gα. Several lines of experimental data support this hypothesis. Electron paramagnetic resonance studies using introduced spin labels on Gαβγ in complex with light-activated rhodopsin suggest that a rigid body rotation of the C-terminal helix of Gα, along with other structural changes, leads to release of the bound nucleotide 19, 20 . NMR spectra of a Gα t /Gα i chimera in complex with detergent-solubilized rhodopsin showed severe line broadening, consistent with a high degree of dynamic disorder when the heterotrimer is in a receptor-bound, nucleotide-free state 21 -a state that is therefore much different than has been visualized in the current repertoire of heterotrimeric G protein structures.
The process by which GPCRs induce this conformational change in Gαβγ remains mysterious. Binding to the extended C terminus of a Gα subunit hardly seems sufficient to coerce global reconfiguration of the entire heterotrimer, particularly when this region of Gα is structurally uncoupled from the rest of the Ras-like domain (the C-terminal receptor-binding region of Gα is almost always disordered in crystal structures of heterotrimeric G proteins). There are several mechanisms by which additional leverage could be applied. First, GPCRs may also interact with other regions of Gα adjacent to the C-terminal helix, such as the αN-β1 and β2-β3 loops at the top of the Ras-like domain, which also collide with the receptor in the opsin-Gαβγ docking model (Fig. 2b,c) . Second, there is some evidence that regions within αN and the lipidmodified N terminus of Gα and the C terminus of Gγ can interact with receptors 22 . Because these structural elements are relatively far from the Gα C terminus (40-50 Å; that is, greater than or equal to the width of the GPCR itself ; see Fig. 2b ), an allosteric change would then have to be brought about via the interactions of Gαβγ with receptors in an oligomeric form. Disfavoring this hypothesis are studies showing that monomeric GPCRs, including the β 2 AR, rhodopsin, and the µ-opioid receptor, are the minimal (albeit not necessarily optimal) units required for hetero trimeric G protein coupling [23] [24] [25] [26] . A third option is that the lipid bilayer itself supplies the necessary leverage required for nucleotide exchange. The structural constraints imposed on Gαβγ by simultaneous interactions with the lipid bilayer, via the lipid modifications at the N terminus of Gα and the C terminus of Gγ, and with the cavity formed in the active GPCR, via the C terminus of Gα, may stabilize the nucleotidefree state of the G protein (Fig. 2b) . This last model is attractive because it does not require each of the individual GPCRs, which show high sequence divergence, to have evolved a unique mechanism to interact with specific Gα subunits at sites other than the C terminus of Gα. GRKs
Problems reading in dim light
As pointed out by others, opsin is orders of magnitude less active than the Meta II state of rhodopsin 8 . Therefore, what state do these structures of opsin really represent? Several observations make this difficult to assess. First, although opsin is far less active than Meta II, the detergent-solubilized protein that was crystallized could still more closely resemble a fully active receptor than the bulk of opsin molecules in solution or in lipid bilayers. After all, GPCRs with basal activity have access to multiple conformational states. Second, if the Gαβγ heterotrimer is docked with the opsin structure using the Gα t peptide as a guide, the N terminus of Gα and the Gβγ subunits overlap extensively with the expected plane of the lipid bilayer 17 ( Fig. 2b,c) . This simple docking exercise could indicate either that the opsin structure is not in a fully activated, G protein-bound conformation or that the model of Gαβγ does not reflect its receptor-bound conformation, or both.
New data, however, reinforce the conclusion that the opsin structures exist in a conformational state at least very close to that of an agonist-occupied receptor. Crystal structures have now been determined for both a constitutively active form of rhodopsin (G. Schertler, personal communication) and an agonist-bound β 2 AR (B. Kobilka, personal communication). In both cases, the receptors adopt conformations very similar to those of opsin, with the expected outward rotation of TM6. Because two distinct GPCRs with properties consistent with those of an activated receptor have now been observed in essentially the same conformation, it seems likely that we now have a reasonably accurate glimpse of what an activated GPCR looks like before it couples with a heterotrimeric G protein. Furthermore, a recent study using genetically encoded, spectroscopically active p-azido-l-phenylalanine mutants of rhodopsin not only confirmed that the opsin structure is consistent with that of an active receptor but also suggested that the inhibited structures reported for other GPCRs, such as that of β 2 AR, represent conformational states more similar to Meta I, an intermediate, inactive conformation of lightactivated rhodopsin in which the G protein binding site has not yet formed 18 .
Future Directions
We are still not at the end of this quest. If one assumes that the structure of the opsin-Gα t peptide complex is similar to that of a receptor bound to a heterotrimeric G protein, then Gαβγ must undergo a significant conformational change to avoid a collision with the cell membrane (Fig. 2b,c) . Reorganization of the heterotrimer is anticipated in any event because the guanine nucleotide needs to be co m m e n ta ry
